Page 171 - DUOKOPT BIBLIOBOOK
P. 171

EFFICACY









                                                                   J Kwon, et al. Cytotoxic Effects of Dorzolamide/timolol



              cells, as well as numerous dead cells as determined by a   thelial cells can proliferate and rabbit corneas can recover
              live/dead cell assay. SEM analysis showed that corneal en-  their normal clarity after endothelial injury on a time scale
              dothelial cells also exhibited a partial loss of microvilli on   of several days to weeks [27,28]. To overcome this limita-
              the surface as well as extensive destruction of intercellular   tion, we evaluated the toxic effects of anti-glaucoma eye-
              junctions. However, corneal edema was mild in the eyes   drops only 24 hours after injection. Therefore, we could
              injected with the preservative-free formulation Cosopt-S,   demonstrate distinct differences between endothelial dam-
              and damage to the corneal endothelium was minimal.   age caused by preservative-containing and preserva-
              Based on the results of this study, we concluded that the   tive-free eyedrops.
              main cause of endothelial toxicity was the preservative,   In conclusion, we demonstrated that the main cause of
              and not the active ingredients of the anti-glaucomatous   endothelial toxicity upon treatment with a dorzol-
              agents. Therefore, anti-glaucoma eyedrops containing pre-  amide-containing solution was due to the preservative, and
              servative may have the potential to cause damage to the   not the active ingredient of this anti-glaucoma medication.
              corneal endothelium as well as to the ocular surface, espe-  Thus, it may be safer to use preservative-free anti-glauco-
              cially during the early postoperative period or in cases of   ma eyedrops during the early postoperative period or in
              an epithelial defect. In these conditions, it seem be safer to   cases where enhanced corneal penetration is a concern.
              use preservative-free anti-glaucoma eyedrops, as several
              studies have already demonstrated that there is no differ-
              ence in intraocular pressure reduction between preserva-  Conflict of Interest
              tive-containing and preservative-free formulations [20-25].
              Moreover, benzalkonium chloride expression has been de-  No potential conflict of interest relevant to this article
              tected in the trabecular meshwork, corneal endothelium,   was reported.
              lens, and retina after topical drop installation, which may
              contribute to toxicity in these tissues [26].
               Our study had a few limitations. In order to evaluate   Acknowledgements
              toxicity, we injected the anti-glaucoma eyedrops directly
              into the anterior chamber. Although the eyedrops were di-  This research was supported by Basic Science Research
              luted, the concentration of anti-glaucoma components and   Program through the National Research Foundation of Ko-
              preservative was most likely greater than the concentra-  rea (NRF) funded by the Ministry of Education, Science
              tions that could be obtained following topical administra-  and Technology (2012R1A1A2042054). This study was
              tion. However, it is difficult to predict the true amount of   supported in part by Alumni of Department of Ophthal-
              eyedrops that enters through clear corneal wounds during   mology, Korea University College of Medicine in 2014.
              the early postoperative period. While it is unusual in clini-
              cal practice that a high concentration of eyedrops could di-
              rectly enter the anterior chamber directly, we reasoned that   References
              direct injection of dorzolamide eyedrops into the anterior
              chamber could represent a case whereby the corneal endo-  1.  Lapalus P, Ettaiche M, Fredj-Reygrobellet D, et al. Cyto-
              thelium is affected, leading to corneal edema. Thus, long-  toxicity studies in ophthalmology. Lens Eye Toxic Res
              term use of topical anti-glaucoma eyedrops may affect the   1990;7:231-42.
              function of the corneal endothelium and eventually can   2.  Guzman-Aranguez A, Calvo P, Ropero I, Pintor J. In vitro
              cause corneal edema. Therefore, our study design may   effects of preserved and unpreserved anti-allergic drugs on
              provide information on the maximal toxic effects of an-  human corneal epithelial cells. J Ocul Pharmacol Ther
              ti-glaucoma eyedrops on the corneal endothelium in the   2014;30:790-8.
              presence or absence of preservative. Another limitation of   3.  Mantelli F, Tranchina L, Lambiase A, Bonini S. Ocular
              this study was the use of rabbits, whose corneal endotheli-  surface damage by ophthalmic compounds. Curr Opin Al-
              al cells are different from human corneal endothelial cells   lergy Clin Immunol 2011;11:464-70.
              in terms of cell proliferation. Indeed, rabbit corneal endo-  4.  Baudouin C, Labbe A, Liang H, et al. Preservatives in eye-



                                                                                                   349


                                                                                                                   171
   166   167   168   169   170   171   172   173   174   175   176